var singsData = [{"date":new Date(2012,1,15),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.4","showOnAxis":true},{"date":new Date(2012,1,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley maintains EMR to Overweight. Target Price is $58; previously $56.","showOnAxis":true},{"date":new Date(2012,1,15),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains EMR to Overweight. Target Price is $58; previously $56.","showOnAxis":false},{"date":new Date(2012,1,24),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,10,14),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.41","showOnAxis":true},{"date":new Date(2012,10,20),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,10,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oppenheimer downgrades EMR to Perform from Outperform. Target Price is $53; previously $57.","showOnAxis":true},{"date":new Date(2012,10,20),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Oppenheimer downgrades EMR to Perform from Outperform. Target Price is $53; previously $57.","showOnAxis":false},{"date":new Date(2012,10,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2012,10,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,10,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,10,6),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, EMR reports 2012 Q4's earning $1.11 per share and revenue $6700MM. This beats analyst's estimated EPS $1.05, beats estimated revenue $6690MM.","showOnAxis":false},{"date":new Date(2012,10,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,10,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,10,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains EMR to Outperform. Target Price is $55; previously $53.","showOnAxis":true},{"date":new Date(2012,10,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oppenheimer maintains EMR to Outperform. Target Price is $57; previously $59.","showOnAxis":true},{"date":new Date(2012,10,7),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains EMR to Outperform. Target Price is $55; previously $53.","showOnAxis":false},{"date":new Date(2012,10,7),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Oppenheimer maintains EMR to Outperform. Target Price is $57; previously $59.","showOnAxis":false},{"date":new Date(2012,11,20),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,11,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bank of America assumes EMR to Neutral. Target Price is $55.","showOnAxis":true},{"date":new Date(2012,11,6),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America assumes EMR to Neutral. Target Price is $55.","showOnAxis":false},{"date":new Date(2012,2,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oppenheimer maintains EMR to Outperform. Target Price is $61; previously $58.","showOnAxis":true},{"date":new Date(2012,2,15),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Oppenheimer maintains EMR to Outperform. Target Price is $61; previously $58.","showOnAxis":false},{"date":new Date(2012,2,21),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,3,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,4,1),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EMR reports 2012 Q2's earning $0.74 per share and revenue $5919MM..","showOnAxis":false},{"date":new Date(2012,4,1),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,4,1),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,4,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains EMR to Outperform. Target Price is $53; previously $55.","showOnAxis":true},{"date":new Date(2012,4,2),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains EMR to Outperform. Target Price is $53; previously $55.","showOnAxis":false},{"date":new Date(2012,4,22),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,4,9),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.4","showOnAxis":true},{"date":new Date(2012,5,26),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,6,19),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,6,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,6,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley maintains EMR to Overweight. Target Price is $56; previously $55.","showOnAxis":true},{"date":new Date(2012,6,30),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains EMR to Overweight. Target Price is $56; previously $55.","showOnAxis":false},{"date":new Date(2012,7,15),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.4","showOnAxis":true},{"date":new Date(2012,7,22),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,7,7),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EMR reports 2012 Q3's earning $1.04 per share and revenue $6484MM..","showOnAxis":false},{"date":new Date(2012,7,7),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,7,7),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,7,7),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,7,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs maintains EMR to Neutral. Target Price is $53; previously $50.","showOnAxis":true},{"date":new Date(2012,7,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains EMR to Neutral. Target Price is $52; previously $49.","showOnAxis":true},{"date":new Date(2012,7,8),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains EMR to Neutral. Target Price is $53; previously $50.","showOnAxis":false},{"date":new Date(2012,7,8),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains EMR to Neutral. Target Price is $52; previously $49.","showOnAxis":false},{"date":new Date(2012,8,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains EMR to Neutral. Target Price is $51; previously $46.","showOnAxis":true},{"date":new Date(2012,8,10),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains EMR to Neutral. Target Price is $51; previously $46.","showOnAxis":false},{"date":new Date(2012,8,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,8,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains EMR to Buy. Target Price is $57; previously $60.","showOnAxis":true},{"date":new Date(2012,8,27),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains EMR to Buy. Target Price is $57; previously $60.","showOnAxis":false},{"date":new Date(2012,8,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains EMR to Buy. Target Price is $57; previously $55.","showOnAxis":true},{"date":new Date(2012,8,5),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains EMR to Buy. Target Price is $57; previously $55.","showOnAxis":false},{"date":new Date(2012,9,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Macquarie downgrades EMR to Neutral from Outperform.","showOnAxis":true},{"date":new Date(2012,9,1),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Macquarie downgrades EMR to Neutral from Outperform.","showOnAxis":false},{"date":new Date(2012,9,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank initiates coverage on EMR to Hold. Target Price is $53.","showOnAxis":true},{"date":new Date(2012,9,12),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank initiates coverage on EMR to Hold. Target Price is $53.","showOnAxis":false},{"date":new Date(2012,9,23),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,0,22),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,0,24),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Deutsche Bank upgrades EMR to Buy from Hold. Target Price is $68; previously $60.","showOnAxis":false},{"date":new Date(2013,0,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains EMR to Hold. Target Price is $60; previously $53.","showOnAxis":true},{"date":new Date(2013,0,7),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains EMR to Hold. Target Price is $60; previously $53.","showOnAxis":false},{"date":new Date(2013,1,13),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.41","showOnAxis":true},{"date":new Date(2013,1,14),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,1,14),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,1,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"RBC Capital initiates coverage on EMR to Outperform. Target Price is $70.","showOnAxis":true},{"date":new Date(2013,1,15),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"RBC Capital initiates coverage on EMR to Outperform. Target Price is $70.","showOnAxis":false},{"date":new Date(2013,1,21),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,1,5),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EMR reports 2013 Q1's earning $0.62 per share and revenue $5553MM..","showOnAxis":false},{"date":new Date(2013,1,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,1,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,1,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,1,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2013,1,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains EMR to Outperform. Target Price is $60; previously $57.","showOnAxis":true},{"date":new Date(2013,1,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Ladenburg Thalmann downgrades EMR to Hold from Buy. Target Price is $60.","showOnAxis":true},{"date":new Date(2013,1,6),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains EMR to Outperform. Target Price is $60; previously $57.","showOnAxis":false},{"date":new Date(2013,1,6),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Ladenburg Thalmann downgrades EMR to Hold from Buy. Target Price is $60.","showOnAxis":false},{"date":new Date(2013,10,13),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.43","showOnAxis":true},{"date":new Date(2013,10,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,10,5),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EMR reports 2013 Q4's earning $1.18 per share  This beats analyst's estimated EPS $1.11.","showOnAxis":false},{"date":new Date(2013,10,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2013,10,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,10,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,10,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,10,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains EMR to Buy. Target Price is $74; previously $72.","showOnAxis":true},{"date":new Date(2013,10,6),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains EMR to Buy. Target Price is $74; previously $72.","showOnAxis":false},{"date":new Date(2013,11,20),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,2,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains EMR to Buy. Target Price is $69; previously $62.","showOnAxis":true},{"date":new Date(2013,2,18),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains EMR to Buy. Target Price is $69; previously $62.","showOnAxis":false},{"date":new Date(2013,2,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs assumes EMR to Neutral. Target Price is $62.","showOnAxis":true},{"date":new Date(2013,2,21),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs assumes EMR to Neutral. Target Price is $62.","showOnAxis":false},{"date":new Date(2013,2,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains EMR to Buy. Target Price is $69; previously $68.","showOnAxis":true},{"date":new Date(2013,2,25),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains EMR to Buy. Target Price is $69; previously $68.","showOnAxis":false},{"date":new Date(2013,2,26),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,2,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Canaccord Genuity initiates coverage on EMR to Hold. Target Price is $60.","showOnAxis":true},{"date":new Date(2013,2,27),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Canaccord Genuity initiates coverage on EMR to Hold. Target Price is $60.","showOnAxis":false},{"date":new Date(2013,3,2),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2013,3,2),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,3,2),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,3,23),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,3,23),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,3,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains EMR to Buy. Target Price is $63; previously $65.","showOnAxis":true},{"date":new Date(2013,3,24),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains EMR to Buy. Target Price is $63; previously $65.","showOnAxis":false},{"date":new Date(2013,4,15),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.41","showOnAxis":true},{"date":new Date(2013,4,20),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,4,7),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EMR reports 2013 Q2's earning $0.77 per share and revenue $5920MM. This misses analyst's estimated EPS $0.78, misses estimated revenue $6030MM.","showOnAxis":false},{"date":new Date(2013,4,7),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,7),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,5,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,6,10),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,6,10),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,6,22),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,6,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"CLSA initiates coverage on EMR to Outperform. Target Price is $64.","showOnAxis":true},{"date":new Date(2013,6,8),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"CLSA initiates coverage on EMR to Outperform. Target Price is $64.","showOnAxis":false},{"date":new Date(2013,7,14),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.41","showOnAxis":true},{"date":new Date(2013,7,21),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EMR reports 2013 Q3's earning $0.97 per share and revenue $6300MM. This misses analyst's estimated EPS $0.98, misses estimated revenue $6440MM.","showOnAxis":false},{"date":new Date(2013,7,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,7,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains EMR to Buy. Target Price is $72; previously $63.","showOnAxis":true},{"date":new Date(2013,7,7),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains EMR to Buy. Target Price is $72; previously $63.","showOnAxis":false},{"date":new Date(2013,7,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains EMR to Buy. Target Price is $68; previously $66.","showOnAxis":true},{"date":new Date(2013,7,8),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains EMR to Buy. Target Price is $68; previously $66.","showOnAxis":false},{"date":new Date(2013,8,20),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,9,21),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,0,22),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,1,12),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.43","showOnAxis":true},{"date":new Date(2014,1,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,1,4),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,1,4),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,4),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,1,4),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2014,10,12),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.47","showOnAxis":true},{"date":new Date(2014,10,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,10,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"RBC Capital initiates coverage on EMR to Sector Perform. Target Price is $69.","showOnAxis":true},{"date":new Date(2014,10,25),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"RBC Capital initiates coverage on EMR to Sector Perform. Target Price is $69.","showOnAxis":false},{"date":new Date(2014,10,4),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2014,10,4),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,10,4),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,10,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $67; previously $64.","showOnAxis":true},{"date":new Date(2014,10,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains EMR to Buy. Target Price is $74; previously $76.","showOnAxis":true},{"date":new Date(2014,10,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains EMR to Buy. Target Price is $77; previously $74.","showOnAxis":true},{"date":new Date(2014,10,5),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $67; previously $64.","showOnAxis":false},{"date":new Date(2014,10,5),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains EMR to Buy. Target Price is $74; previously $76.","showOnAxis":false},{"date":new Date(2014,10,5),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains EMR to Buy. Target Price is $77; previously $74.","showOnAxis":false},{"date":new Date(2014,11,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank downgrades EMR to Hold from Buy.","showOnAxis":true},{"date":new Date(2014,11,12),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank downgrades EMR to Hold from Buy.","showOnAxis":false},{"date":new Date(2014,11,22),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,11,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bank of America maintains EMR to Neutral. Target Price is $66; previously $68.","showOnAxis":true},{"date":new Date(2014,11,5),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America maintains EMR to Neutral. Target Price is $66; previously $68.","showOnAxis":false},{"date":new Date(2014,2,21),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Oppenheimer upgrades EMR to Outperform from Market Perform. Target Price is $77.","showOnAxis":false},{"date":new Date(2014,2,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,3,23),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,3,23),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,3,30),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2014,3,30),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,3,30),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2014,3,30),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Termination of a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2014,4,14),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.43","showOnAxis":true},{"date":new Date(2014,4,21),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,4,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,4,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,5,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,6,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,7,13),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.43","showOnAxis":true},{"date":new Date(2014,7,22),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,7,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,7,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,7,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $64; previously $66.","showOnAxis":true},{"date":new Date(2014,7,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains EMR to Buy. Target Price is $76; previously $84.","showOnAxis":true},{"date":new Date(2014,7,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oppenheimer maintains EMR to Outperform. Target Price is $70; previously $77.","showOnAxis":true},{"date":new Date(2014,7,6),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $64; previously $66.","showOnAxis":false},{"date":new Date(2014,7,6),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains EMR to Buy. Target Price is $76; previously $84.","showOnAxis":false},{"date":new Date(2014,7,6),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Oppenheimer maintains EMR to Outperform. Target Price is $70; previously $77.","showOnAxis":false},{"date":new Date(2014,7,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains EMR to Neutral. Target Price is $69; previously $72.","showOnAxis":true},{"date":new Date(2014,7,8),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains EMR to Neutral. Target Price is $69; previously $72.","showOnAxis":false},{"date":new Date(2014,8,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus initiates coverage on EMR to Buy. Target Price is $81.","showOnAxis":true},{"date":new Date(2014,8,17),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus initiates coverage on EMR to Buy. Target Price is $81.","showOnAxis":false},{"date":new Date(2014,8,24),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,8,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Buckingham Research initiates coverage on EMR to Neutral. Target Price is $67.","showOnAxis":true},{"date":new Date(2014,8,5),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Buckingham Research initiates coverage on EMR to Neutral. Target Price is $67.","showOnAxis":false},{"date":new Date(2014,9,22),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,9,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Wells Fargo downgrades EMR to Market Perform from Outperform.","showOnAxis":true},{"date":new Date(2014,9,29),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Wells Fargo downgrades EMR to Market Perform from Outperform.","showOnAxis":false},{"date":new Date(2015,0,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $66; previously $67.","showOnAxis":true},{"date":new Date(2015,0,12),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $66; previously $67.","showOnAxis":false},{"date":new Date(2015,0,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains EMR to Neutral. Target Price is $62; previously $67.","showOnAxis":true},{"date":new Date(2015,0,15),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains EMR to Neutral. Target Price is $62; previously $67.","showOnAxis":false},{"date":new Date(2015,0,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Baird downgrades EMR to Neutral from Outperform. Target Price is $65; previously $74.","showOnAxis":true},{"date":new Date(2015,0,22),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Baird downgrades EMR to Neutral from Outperform. Target Price is $65; previously $74.","showOnAxis":false},{"date":new Date(2015,0,26),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,0,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains EMR to Buy. Target Price is $67; previously $74.","showOnAxis":true},{"date":new Date(2015,0,29),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains EMR to Buy. Target Price is $67; previously $74.","showOnAxis":false},{"date":new Date(2015,0,9),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,0,9),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,1,11),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.47","showOnAxis":true},{"date":new Date(2015,1,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains EMR to Buy. Target Price is $66; previously $64.","showOnAxis":true},{"date":new Date(2015,1,20),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains EMR to Buy. Target Price is $66; previously $64.","showOnAxis":false},{"date":new Date(2015,1,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains EMR to Neutral. Target Price is $59; previously $58.","showOnAxis":true},{"date":new Date(2015,1,23),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains EMR to Neutral. Target Price is $59; previously $58.","showOnAxis":false},{"date":new Date(2015,1,24),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,1,3),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,1,3),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,1,3),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,1,3),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2015,1,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains EMR to Buy. Target Price is $66; previously $67.","showOnAxis":true},{"date":new Date(2015,1,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains EMR to Neutral. Target Price is $60; previously $62.","showOnAxis":true},{"date":new Date(2015,1,4),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains EMR to Buy. Target Price is $66; previously $67.","showOnAxis":false},{"date":new Date(2015,1,4),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains EMR to Neutral. Target Price is $60; previously $62.","showOnAxis":false},{"date":new Date(2015,1,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains EMR to Neutral. Target Price is $58; previously $62.","showOnAxis":true},{"date":new Date(2015,1,6),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains EMR to Neutral. Target Price is $58; previously $62.","showOnAxis":false},{"date":new Date(2015,1,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Atlantic Equities downgrades EMR to Neutral from Overweight. Target Price is $59; previously $74.","showOnAxis":true},{"date":new Date(2015,1,9),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Atlantic Equities downgrades EMR to Neutral from Overweight. Target Price is $59; previously $74.","showOnAxis":false},{"date":new Date(2015,10,10),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.475","showOnAxis":true},{"date":new Date(2015,10,3),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EMR reports 2015 Q4's earning $0.93 per share and revenue $5814MM. This misses analyst's estimated EPS $0.97, misses estimated revenue $5830MM.","showOnAxis":false},{"date":new Date(2015,10,3),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,3),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,10,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains EMR to Buy. Target Price is $56; previously $51.","showOnAxis":true},{"date":new Date(2015,10,4),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains EMR to Buy. Target Price is $56; previously $51.","showOnAxis":false},{"date":new Date(2015,10,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Societe Generale downgrades EMR to Hold from Buy.","showOnAxis":true},{"date":new Date(2015,10,5),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Societe Generale downgrades EMR to Hold from Buy.","showOnAxis":false},{"date":new Date(2015,11,21),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,11,7),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,2,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $63; previously $66.","showOnAxis":true},{"date":new Date(2015,2,17),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $63; previously $66.","showOnAxis":false},{"date":new Date(2015,3,24),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,3,24),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,3,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $61; previously $63.","showOnAxis":true},{"date":new Date(2015,3,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"RBC Capital maintains EMR to Sector Perform. Target Price is $58; previously $60.","showOnAxis":true},{"date":new Date(2015,3,27),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $61; previously $63.","showOnAxis":false},{"date":new Date(2015,3,27),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"RBC Capital maintains EMR to Sector Perform. Target Price is $58; previously $60.","showOnAxis":false},{"date":new Date(2015,3,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,3,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,4,13),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.47","showOnAxis":true},{"date":new Date(2015,4,18),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,18),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,4,20),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,4,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains EMR to Buy. Target Price is $66; previously $63.","showOnAxis":true},{"date":new Date(2015,4,22),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains EMR to Buy. Target Price is $66; previously $63.","showOnAxis":false},{"date":new Date(2015,4,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,4,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"RBC Capital maintains EMR to Sector Perform. Target Price is $56; previously $58.","showOnAxis":true},{"date":new Date(2015,4,6),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"RBC Capital maintains EMR to Sector Perform. Target Price is $56; previously $58.","showOnAxis":false},{"date":new Date(2015,5,22),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,5,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Baird maintains EMR to Neutral. Target Price is $59; previously $58.","showOnAxis":true},{"date":new Date(2015,5,23),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Baird maintains EMR to Neutral. Target Price is $59; previously $58.","showOnAxis":false},{"date":new Date(2015,5,30),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,5,30),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,6,13),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $54; previously $55.","showOnAxis":true},{"date":new Date(2015,6,13),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $54; previously $55.","showOnAxis":false},{"date":new Date(2015,6,20),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,6,23),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,7,12),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.47","showOnAxis":true},{"date":new Date(2015,7,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,7,26),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Vertical Research upgrades EMR to Buy from Hold.","showOnAxis":false},{"date":new Date(2015,7,4),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,7,4),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,7,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $53; previously $54.","showOnAxis":true},{"date":new Date(2015,7,5),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $53; previously $54.","showOnAxis":false},{"date":new Date(2015,7,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Argus Research downgrades EMR to Hold from Buy.","showOnAxis":true},{"date":new Date(2015,7,6),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Argus Research downgrades EMR to Hold from Buy.","showOnAxis":false},{"date":new Date(2015,8,22),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,8,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Societe Generale maintains EMR to Buy. Target Price is $56; previously $61.","showOnAxis":true},{"date":new Date(2015,8,23),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Societe Generale maintains EMR to Buy. Target Price is $56; previously $61.","showOnAxis":false},{"date":new Date(2015,9,16),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,9,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $46; previously $53.","showOnAxis":true},{"date":new Date(2015,9,5),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $46; previously $53.","showOnAxis":false},{"date":new Date(2015,9,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,0,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $47; previously $46.","showOnAxis":true},{"date":new Date(2016,0,19),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $47; previously $46.","showOnAxis":false},{"date":new Date(2016,0,20),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Standpoint Research upgrades EMR to Buy from Hold.","showOnAxis":false},{"date":new Date(2016,0,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup initiates coverage on EMR to Sell.","showOnAxis":true},{"date":new Date(2016,0,21),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup initiates coverage on EMR to Sell.","showOnAxis":false},{"date":new Date(2016,1,10),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.475","showOnAxis":true},{"date":new Date(2016,1,17),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,1,2),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EMR reports 2016 Q1's earning $0.56 per share and revenue $4713MM. This beats analyst's estimated EPS $0.51, beats estimated revenue $4640MM.","showOnAxis":false},{"date":new Date(2016,1,2),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,1,2),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,1,2),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,1,2),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2016,1,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Standpoint Research downgrades EMR to Hold from Buy.","showOnAxis":true},{"date":new Date(2016,1,29),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Standpoint Research downgrades EMR to Hold from Buy.","showOnAxis":false},{"date":new Date(2016,1,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Baird maintains EMR to Neutral. Target Price is $49; previously $55.","showOnAxis":true},{"date":new Date(2016,1,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains EMR to Buy. Target Price is $51; previously $50.","showOnAxis":true},{"date":new Date(2016,1,3),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Baird maintains EMR to Neutral. Target Price is $49; previously $55.","showOnAxis":false},{"date":new Date(2016,1,3),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains EMR to Buy. Target Price is $51; previously $50.","showOnAxis":false},{"date":new Date(2016,10,1),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EMR reports 2016 Q4's earning $0.96 per share and revenue $3932MM. This beats analyst's estimated EPS $0.9, misses estimated revenue $5510MM.","showOnAxis":false},{"date":new Date(2016,10,1),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,10,1),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,10,8),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.48","showOnAxis":true},{"date":new Date(2016,2,14),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains EMR to Outperform. Target Price is $55; previously $54.","showOnAxis":true},{"date":new Date(2016,2,14),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains EMR to Outperform. Target Price is $55; previously $54.","showOnAxis":false},{"date":new Date(2016,2,16),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,3,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $54; previously $47.","showOnAxis":true},{"date":new Date(2016,3,18),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $54; previously $47.","showOnAxis":false},{"date":new Date(2016,3,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains EMR to Sell. Target Price is $49; previously $41.","showOnAxis":true},{"date":new Date(2016,3,19),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains EMR to Sell. Target Price is $49; previously $41.","showOnAxis":false},{"date":new Date(2016,4,11),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Argus Research upgrades EMR to Buy from Hold.","showOnAxis":false},{"date":new Date(2016,4,11),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.475","showOnAxis":true},{"date":new Date(2016,4,18),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,4,3),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,3),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,5,22),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,6,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $55; previously $56.","showOnAxis":true},{"date":new Date(2016,6,18),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $55; previously $56.","showOnAxis":false},{"date":new Date(2016,6,29),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2016,6,29),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,6,29),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,6,30),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,6,30),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,6,30),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,7,1),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EMR reports 2016 Q3's earning $0.8 per share and revenue $5126MM. This misses analyst's estimated EPS $0.84, misses estimated revenue $5330MM.","showOnAxis":false},{"date":new Date(2016,7,10),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.475","showOnAxis":true},{"date":new Date(2016,7,18),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2016,7,18),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,7,18),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,7,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Buckingham Research downgrades EMR to Underperform from Neutral. Target Price is $44; previously $49.","showOnAxis":true},{"date":new Date(2016,7,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse downgrades EMR to Neutral from Outperform. Target Price is $57.","showOnAxis":true},{"date":new Date(2016,7,19),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Buckingham Research downgrades EMR to Underperform from Neutral. Target Price is $44; previously $49.","showOnAxis":false},{"date":new Date(2016,7,19),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse downgrades EMR to Neutral from Outperform. Target Price is $57.","showOnAxis":false},{"date":new Date(2016,7,2),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2016,7,2),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,7,2),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,7,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $53; previously $55.","showOnAxis":true},{"date":new Date(2016,7,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"CLSA downgrades EMR to Underperform from Sell.","showOnAxis":true},{"date":new Date(2016,7,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains EMR to Sell. Target Price is $48; previously $49.","showOnAxis":true},{"date":new Date(2016,7,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains EMR to Buy. Target Price is $58; previously $60.","showOnAxis":true},{"date":new Date(2016,7,3),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains EMR to Equal-Weight. Target Price is $53; previously $55.","showOnAxis":false},{"date":new Date(2016,7,3),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"CLSA downgrades EMR to Underperform from Sell.","showOnAxis":false},{"date":new Date(2016,7,3),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains EMR to Sell. Target Price is $48; previously $49.","showOnAxis":false},{"date":new Date(2016,7,3),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains EMR to Buy. Target Price is $58; previously $60.","showOnAxis":false},{"date":new Date(2016,7,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains EMR to Neutral. Target Price is $53; previously $56.","showOnAxis":true},{"date":new Date(2016,7,4),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains EMR to Neutral. Target Price is $53; previously $56.","showOnAxis":false},{"date":new Date(2016,7,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains EMR to Hold. Target Price is $50; previously $55.","showOnAxis":true},{"date":new Date(2016,7,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan assumes EMR to Neutral. Target Price is $47.","showOnAxis":true},{"date":new Date(2016,7,8),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains EMR to Hold. Target Price is $50; previously $55.","showOnAxis":false},{"date":new Date(2016,7,8),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan assumes EMR to Neutral. Target Price is $47.","showOnAxis":false},{"date":new Date(2016,8,22),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,9,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS downgrades EMR to Sell from Neutral.","showOnAxis":true},{"date":new Date(2016,9,12),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS downgrades EMR to Sell from Neutral.","showOnAxis":false},{"date":new Date(2016,9,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Berenberg initiates coverage on EMR to Sell. Target Price is $41.","showOnAxis":true},{"date":new Date(2016,9,3),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Berenberg initiates coverage on EMR to Sell. Target Price is $41.","showOnAxis":false},{"date":new Date(2016,9,4),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2016,9,4),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,9,4),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,9,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"HSBC initiates coverage on EMR.","showOnAxis":true},{"date":new Date(2016,9,7),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"HSBC initiates coverage on EMR.","showOnAxis":false},{"date":new Date(2017,0,27),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades EMR to Neutral from Sell.","showOnAxis":false},{"date":new Date(2017,1,7),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EMR reports 2017 Q1's earning $0.49 per share and revenue $3216MM. This beats analyst's estimated EPS $0.42, beats estimated revenue $3170MM.","showOnAxis":false},{"date":new Date(2017,1,8),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"UBS upgrades EMR to Neutral from Sell. Target Price is $64; previously $51.","showOnAxis":false}];